Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaoki Ito

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.
Cell Communication and Signaling : CCS|October 30, 2019
Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinomaMasaoki Ito, Carles Codony-Servat, Jordi Codony-Servat, et al.
Annals of Translational Medicine|January 14, 2020
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinomaImane Chaib, Xueting Cai, David Llige, et al.
JTO Clinical and Research Reports|September 30, 2021
Src-Homology 2 Domain-Containing Phosphatase 2 in Resected <i>EGFR</i> Mutation-Positive Lung AdenocarcinomaMasaoki Ito, Jordi Codony-Servat, Ana Giménez-Capitán, et al.
Molecular Oncology|January 21, 2022
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimensCarlos Pedraz-Valdunciel, Stavros Giannoukakos, Nicolas Potie, et al.
Ebiomedicine|April 13, 2023
Macrophage CD5L is a target for cancer immunotherapyLidia Sanchez-Moral, Tony Paul, Clara Martori, et al.
Cell Communication and Signaling : CCS|June 12, 2024
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combinationRafael Rosell, Eloisa Jantus-Lewintre, Peng Cao, et al.
Ebiomedicine|February 14, 2018
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor PrognosisNiki Karachaliou, Imane Chaib, Andres Felipe Cardona, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective studyMichihito Toda, Kazuki Takada, Kotaro Nomura, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.
Cell Communication and Signaling : CCS|October 30, 2019
Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinomaMasaoki Ito, Carles Codony-Servat, Jordi Codony-Servat, et al.
Annals of Translational Medicine|January 14, 2020
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinomaImane Chaib, Xueting Cai, David Llige, et al.
JTO Clinical and Research Reports|September 30, 2021
Src-Homology 2 Domain-Containing Phosphatase 2 in Resected <i>EGFR</i> Mutation-Positive Lung AdenocarcinomaMasaoki Ito, Jordi Codony-Servat, Ana Giménez-Capitán, et al.
Molecular Oncology|January 21, 2022
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimensCarlos Pedraz-Valdunciel, Stavros Giannoukakos, Nicolas Potie, et al.
Ebiomedicine|April 13, 2023
Macrophage CD5L is a target for cancer immunotherapyLidia Sanchez-Moral, Tony Paul, Clara Martori, et al.
Cell Communication and Signaling : CCS|June 12, 2024
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combinationRafael Rosell, Eloisa Jantus-Lewintre, Peng Cao, et al.
Ebiomedicine|February 14, 2018
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor PrognosisNiki Karachaliou, Imane Chaib, Andres Felipe Cardona, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective studyMichihito Toda, Kazuki Takada, Kotaro Nomura, et al.
Pageof 7